learn-at-home-series

With the emergence of coronavirus (COVID-19), have you found yourself working from home with a little extra time on your hands? If your lab has temporarily closed or you have an open calendar due to the postponement of AACR, there is no better time to check out our new Learn at Home Series: Oncology. Taconic Biosciences' experts have pulled together a series of learning modules and materials to enable you to continue learning outside of the lab during this time.

This free Learn at Home Series includes:

  • Highly popular pre-recorded webinars
  • Two new white papers on humanized immune system mice, with information on their application to oncology research
  • Virtual poster session with posters from past oncology meetings
  • Opportunity to schedule a one-on-one meeting with a Taconic oncology expert

Participants may request a certificate of attendance for this series by emailing stacy.wennstrom@taconic.com.

Get Started Today »

Course materials include:

You may pick and choose based on your specific interests and work at your own pace.

Humanized mice for immuno-oncology series:

  • Register Now! WEBINAR Beyond HSCs: Humanized Immune System Models based on PBMCs and isolated immune cell subsets
  • New! WHITE PAPER An Introduction to Humanized Immune System Mouse Models
  • New! WHITE PAPER Humanized Mouse Models for Drug Discovery: The NOG Portfolio
  • ON-DEMAND WEBINAR Humanized Mice in Preclinical Immuno-Oncology - Part I
  • ON-DEMAND WEBINAR Humanized Mice in Preclinical Immuno-Oncology - Part II
  • ON-DEMAND WEBINAR Development of Human NK Cells in hIL-2 NOG and hIL-15Tg Mice
  • ON-DEMAND WEBINAR Development and Characteristics of hIL-6 NOG Mouse

Cell line-derived (CDX) and patient-derived xenograft (PDX) series:

  • WHITE PAPER Xenograft Host Selection: Important Factors for Experimental Success
  • ON-DEMAND WEBINAR The Ultimate Xenograft Host Comparison Guide
  • ON-DEMAND WEBINAR Patient-Derived Xenografts on Humanized Mice
  • ON-DEMAND WEBINAR Next Generation Humanized Mice for Acute Myeloid Leukemia (AML) and Natural Killer (NK) Cell Therapy Testing
  • ON-DEMAND WEBINAR Patient-Derived Xenografts (PDX) of Hematological Malignancies: Model Systems for Drug Development and Tumor Biology Research
  • ON-DEMAND WEBINAR Modeling Prostate Cancer Therapies with Humanized Mice
  • ON-DEMAND WEBINAR A New Humanized Mouse Model of Tumor Growth in Bone for Testing Immunotherapies
  • ON-DEMAND WEBINAR Estrogen-Related Effects in Breast Cancer Xenograft Models

Syngeneic tumor series:

  • ON-DEMAND WEBINAR Advanced Toolkit for Syngeneic Tumor Modeling in Mice
  • VIDEO Genetic Background in Syngeneic Models
  • VIDEO The Jh mouse permits clinically relevant dosing of immunogenic test articles in syngeneic tumor model systems
  • INFOGRAPHIC The Jh mouse permits clinically relevant dosing of immunogenic test articles in syngeneic tumor model systems

Cell Line Databases:

  • Syngeneic Cell Line Database
  • Xenograft Cell Line Database

Virtual Poster Session

Insights:

  • What is a Xenograft?
  • Webinar Q&A — Advanced Toolkit for Syngeneic Tumor Modeling in Mice
  • Webinar Q&A — Humanized Mice in Preclinical Immuno-Oncology
  • Webinar Q&A — Next Generation Humanized Mice in IO
  • The IL-2 NOG: An Optimal Model for the Testing of CAR T cell Therapy in Solid Tumors
  • Benefits of Humanized Mice for CAR-T Immunotherapy Studies
  • Evaluating IO Bispecifics with PBMC-Humanized Mice
  • Obstacles to Efficacy Testing of Biologic Therapies in Mice - Anti-Drug Antibody Development
  • New Options for IO Efficacy Testing
  • Patient-Derived Xenografts Q&A with Dr. Els Hermans

Enroll Now

© 2024 Taconic Biosciences, Inc. All rights reserved.

© 2024 Taconic Biosciences, Inc. All rights reserved.